DIN 58989
Haemostaseology - HPLC-MS methods for the quantification of direct oral anticoagulants (DOAC) - Rivaroxaban; Text in German and English
active, Most Current
| Organization: | DIN |
| Publication Date: | 1 October 2018 |
| Status: | active |
| Page Count: | 24 |
| ICS Code (Analysis of blood and urine): | 11.100.30 |
scope:
This standard specifies methods for measuring concentrations of the direct oral anticoagulant (DOAC) rivaroxaban in human plasma samples.
This document applies to developers and manufacturers of rivaroxaban assays, medical laboratories, as well as institutions and commercial organizations performing biomedical research.
Document History
DIN 58989
October 1, 2018
Haemostaseology - HPLC-MS methods for the quantification of direct oral anticoagulants (DOAC) - Rivaroxaban; Text in German and English
This standard specifies methods for measuring concentrations of the direct oral anticoagulant (DOAC) rivaroxaban in human plasma samples.
This document applies to developers and manufacturers of...
November 1, 2017
Haemostaseology - HPLC-MS methods for the quantification of direct oral anticoagulants (DOAC) - Rivaroxaban; Text in German and English
A description is not available for this item.